We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Scientific Session Explores Role of Technology in New Era of Specimen Transport

By LabMedica International staff writers
Posted on 27 Jul 2023

Regardless of a lab's scale or complexity, patient samples require transportation prior to testing. More...

From moving specimens across a room to shipping them globally, all labs inevitably encounter challenges at some point. The AACC 2023 session titled "Advances in Courier, Drone, and Automated Laboratory Transport" empowered attendees with the understanding of how issues and inefficiencies in sample transport could impact test results. Moreover, the session also threw light on how emerging technologies can be harnessed to streamline testing and maintain specimen quality.

Session moderator Joe Wiencek, Ph.D. from the Vanderbilt University School of Medicine (Nashville, TN, USA) argued that despite the critical role of patient specimens in testing, the sector hasn't paid adequate attention to specimen transport conditions. At his institution, Wiencek has employed innovative devices to record conditions during specimen transport, such as temperature, humidity, and G-forces. He expressed considerable concern over the practice at external collection sites of storing samples in outdoor lockboxes while waiting for courier pick-up, particularly given the intense heat in his region. However, in the absence of benchmarks and standards for specimen transport, it's challenging for laboratories to take proactive steps. Wiencek shared plans for new Clinical and Laboratory Standards Institute (CLSI, Berwyn, PA, USA) documents that address specimen preanalytics, particularly PRE-06 Evaluation of External Transport Systems, which he is co-authoring. The attendees left the session equipped with a set of tools to overcome their sample transport hurdles.

Timothy Amukele, MD, from ICON Clinical Research (Farmingdale, MD, USA) expanded the discussion about external sample transport by introducing the concept of medical drone transport. While medical drones might seem like a concept straight out of a science fiction novel for some, they are very much a reality in certain parts of the world. Dr. Amukele highlighted how African governments are leading the charge in harnessing these technologies effectively. He cited the example of Rwanda, where drones are used to deliver life-saving blood products to remote hospitals, along with similar implementations in other countries. Dr. Amukele believes that these success stories are noteworthy and succeeded in convincing the attendees of the viability of medical drones in specimen transportation.

However, the application of drone transportation isn't limited to isolated regions. There's considerable interest in deploying this technology in densely populated urban areas as well. Dr. Amukele shared his personal experience of spearheading a medical drone research team in the United States, shedding light on the steps required to establish a medical drone transport network. He stressed that medical drones have already shown their worth in real-world applications and expressed his wish to see their usage further expand within laboratory practice.

Jonathan Genzen, MD, Ph.D., from ARUP Laboratories (Salt Lake City, UT, USA) shifted the focus of the discussion to sample transportation and automation within healthcare facilities and laboratories. His objective at his institution is to automate routine, non-value-adding steps in the testing process, thereby allowing professionals to concentrate on complex tasks that demand human expertise. Genzen recounted his experiences in integrating automated intelligent vehicles for sample transportation. These non-track-based mobile robots are suitable for specimen distribution and are equipped with sensors to navigate their surroundings, avoiding collisions with objects and individuals. He also discussed lessons in automation derived from the COVID-19 pandemic. Attendees gained insights into how they can modernize their specimen transport procedures. Genzen emphasized that labs can implement simple, easy improvements to reap substantial benefits from minimal investments.

Related Links:
Vanderbilt University
ICON Clinical Research
ARUP Laboratories 
CLSI


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Capillary testing on the Atellica analyzers supports the most common laboratory testing needs (Photo courtesy of Siemens Healthineers)

Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers

Venous blood draws can be challenging in patients with difficult veins, needle phobia, or limited blood volume, and they can slow collection in busy services. Core laboratories also face pressure to expand... Read more

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.